Home Stocks Maxigen Biotech Inc. Shareholders Maxigen Biotech Inc. · TWSE:1783
Maxigen Biotech Inc. shareholders Maxigen Biotech Inc. on 6ix: holders from Taiwan's exchanges and US fund reports. Largest: 大江生醫股份有限公司, 台塑生醫科技股份有限公司 and 中加投資發展股份有限公司. Each with its filing.
Shareholders Register Holder Shares Of the company As of 大江生醫股份有限公司 28M 31.2% Oct 31, 2026 台塑生醫科技股份有限公司 8.7M 9.7% Oct 31, 2026 中加投資發展股份有限公司 1.38M 1.5% Oct 31, 2026 林詠翔 588K 0.66% Oct 31, 2026 陳敬亭 146K 0.16% Oct 31, 2026 賴柏宏 85,997 0.10% Oct 31, 2026 林欣榮 0 0.00% Oct 31, 2026 吳瑞益 0 0.00% Oct 31, 2026 曾仲銘 0 0.00% Oct 31, 2026 李啟睿 0 0.00% Oct 31, 2026 陳適安 0 0.00% Oct 31, 2026 廖松淵 0 0.00% Oct 31, 2026 賴世明 0 0.00% Oct 31, 2026 黃振嘉 0 0.00% Oct 31, 2026 李秋月 0 0.00% Oct 31, 2026 大江生醫股份有限公司 Nov 22, 2026
Funds Holder Shares Value As of Emerging Markets Core Equity 2 Portfolio 219K US$269K Jul 31, 2026 Dimensional Emerging Markets Core Equity 2 ETF 57,000 US$70,282 Jul 31, 2026 The Emerging Markets Small Cap Series 48,600 US$59,877 Jul 31, 2026 Dimensional World ex. U.S. Core Equity 2 ETF 36,000 US$44,389 Jul 31, 2026 World ex U.S. Core Equity Portfolio 18,000 US$22,177 Jul 31, 2026 Dimensional Emerging Core Equity Market ETF 14,700 US$18,125 Jul 31, 2026 Emerging Markets Social Core Equity Portfolio 13,650 US$16,817 Jul 31, 2026 Emerging Markets ex China Core Equity Portfolio 3,000 US$3,696 Jul 31, 2026